Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Guler Yavas MD

Instructor

Institution: Medical College of Wisconsin
Department: Radiation Oncology

Publications (69)

  • Failure patterns and the influence of the TNM staging systems on prognosis in limited disease small cell lung Cancer (SCLC): the Turkish Oncology Group (TOG) study. (Ergen ŞA, Dinçbaş FÖ, Metcalfe E, Gül ŞK, Akyürek S, Yavaş G, Özdemir BŞ, Yücel B, Altınok A, Atalar B, Altınok P, Yakar M, Tepetam H, Birgi SD, Yavaş Ç, Korcum AF, Tatlı AM, Yumuk F) Clin Transl Oncol 2026 Apr;28(4):1234-1245 PMID: 41134441 SCOPUS ID: 2-s2.0-105029262579 10/24/2025    
  • Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation Oncology Thoracic Cancer Study Group (08-005). (Gumustepe E, Yavas G, Kirakli EK, Dincbas FÖ, N D, Hurmuz P, Koksoy EB, Catal TK, Özler T, Yilmaz Aslan MT, Akyurek S) Am J Clin Oncol 2025 Feb 01;48(2):67-74 PMID: 39434398 SCOPUS ID: 2-s2.0-85207453514 10/22/2024       2 Citations
  • Dosimetric evaluation of ultrafractionated dose escalation with simultaneous integrated boost to intraprostatic lesion using 1.5-Tesla MR-Linac in localized prostate cancer. (Onal C, Arslan G, Yavas C, Efe E, Yavas G) Rep Pract Oncol Radiother 2024;29(1):10-20 PMID: 39165591 PMCID: PMC11333072 SCOPUS ID: 2-s2.0-85188624753 08/21/2024       4 Citations
  • Assessing the prognostic role of panimmune inflammation in high-grade gliomas. (Kavak EE, Dilli İ, Yavaş G) Clin Transl Oncol 2025 Mar;27(3):1320-1328 PMID: 39141278 SCOPUS ID: 2-s2.0-85201201338 08/14/2024       1 Citation
  • The impact of margin reduction on radiation dose distribution of ultra-hypofractionated prostate radiotherapy utilizing a 1.5-T MR-Linac. (Onal C, Efe E, Bozca R, Yavas C, Yavas G, Arslan G) J Appl Clin Med Phys 2024 Jan;25(1):e14179 PMID: 38013636 PMCID: PMC10795449 SCOPUS ID: 2-s2.0-85177999493 11/28/2023       5 Citations
  • Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study. (Guler OC, Oymak E, Yazici G, Akagunduz OO, Cetinayak O, Erpolat P, Aksoy A, Duzova M, Yildirim BA, Kurt M, Canyilmaz E, Yavas G, Akyurek S, Oksuz DC, Saglam EK, Celik OK, Ozyar E, Cengiz M, Onal C) Oncol Res 2023;31(3):299-306 PMID: 37305394 PMCID: PMC10229304 SCOPUS ID: 2-s2.0-85161401689 06/12/2023       2 Citations
  • Radiation-induced Desmoid Tumor Development in the Radiotherapy Field in a Child With Pineoblastoma: A Case Report. (Isik Bedir S, Karabagli P, Batur A, Ozturk M, Karabagli H, Yavas G, Koksal Y) J Pediatr Hematol Oncol 2023 Jul 01;45(5):e639-e642 PMID: 37278565 SCOPUS ID: 2-s2.0-85163846527 06/06/2023       2 Citations
  • Multi-institutional study on the role of post-operative radiotherapy in elderly patients with endometrial cancer. (Yavas G, Guler OC, Gultekin M, Oymak E, Yuce Sari S, Yildiz F, Onal C) Int J Gynecol Cancer 2023 May 01;33(5):719-726 PMID: 36635049 SCOPUS ID: 2-s2.0-85158862229 01/13/2023       1 Citation
  • Oncological outcomes for encapsulated papillary carcinoma of the breast: Multicentric study of Turkish Society for Radiation Oncology breast cancer study group (TROD 06-014 study). (Gurdal N, Yildirim BA, Gursel OK, Ozkurt S, Ibis K, Gultekin M, Tepetam H, Gul SK, Guzeloz Z, Oksuz DC, Cetin IA, Yalcin B, Duzova M, Kanyilmaz G, Yavas G, Ozsaran Z) Asia Pac J Clin Oncol 2023 Oct;19(5):e273-e282 PMID: 36464924 SCOPUS ID: 2-s2.0-85143991946 12/06/2022       3 Citations
  • Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma. (Guler OC, Oymak E, Hurmuz P, Yavas G, Tilki B, Yavas C, Ozyigit G, Onal C) Urol Int 2023;107(2):171-178 PMID: 36455527 SCOPUS ID: 2-s2.0-85144122927 12/02/2022       1 Citation
  • Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study. (Onal C, Oymak E, Guler OC, Tilki B, Yavas G, Hurmuz P, Yavas C, Ozyigit G) Strahlenther Onkol 2023 May;199(5):456-464 PMID: 36450836 SCOPUS ID: 2-s2.0-85142929940 12/01/2022       4 Citations
  • The utility of 1.5 tesla MR-guided adaptive stereotactic body radiotherapy for recurrent ovarian tumor - Case reports and review of the literature. (Yavas G, Kuscu UE, Ayhan A, Yavas C, Onal C) Int J Surg Case Rep 2022 Oct;99:107696 PMID: 36261943 PMCID: PMC9568843 SCOPUS ID: 2-s2.0-85139350940 10/21/2022       5 Citations
  • Cardiac angiosarcoma treated with 1.5 Tesla MR-guided adaptive stereotactic body radiotherapy - Case report and review of the literature. (Noyan A, Yavas G, Efe E, Arslan G, Yavas C, Onal C) Int J Surg Case Rep 2022 Sep;98:107521 PMID: 36027835 PMCID: PMC9424346 SCOPUS ID: 2-s2.0-85136578681 08/27/2022       9 Citations
  • Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study. (Onal C, Guler OC, Hurmuz P, Yavas G, Tilki B, Oymak E, Yavas C, Ozyigit G) Strahlenther Onkol 2022 Oct;198(10):940-948 PMID: 35695908 SCOPUS ID: 2-s2.0-85131738517 06/14/2022       10 Citations
  • The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy. (Onal C, Gultekin M, Yavas G, Oymak E, Yuce Sari S, Guler OC, Yigit E, Yildiz F) J Obstet Gynaecol 2022 Aug;42(6):2426-2432 PMID: 35653776 SCOPUS ID: 2-s2.0-85131563301 06/03/2022       8 Citations
  • Stereotactic Ablative Body Radiotherapy as a Bridge to Liver Transplant for Hepatocellular Carcinoma: Preliminary Results of Başkent University Experience. (Yavas G, Ayvazoglu Soy EH, Coskun M, Onal C, Boyvat F, Haberal M) Exp Clin Transplant 2022 Mar;20(Suppl 1):39-45 PMID: 35384806 SCOPUS ID: 2-s2.0-85127715330 04/07/2022    
  • The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma. (Onal C, Hurmuz P, Guler OC, Yavas G, Tilki B, Oymak E, Yavas C, Ozyigit G) Clin Transl Oncol 2022 Aug;24(8):1533-1541 PMID: 35119653 SCOPUS ID: 2-s2.0-85124206780 02/05/2022       10 Citations
  • In Regard to de Groot et al. (Yavas G, Yavas C, Onal C) Int J Radiat Oncol Biol Phys 2021 Dec 01;111(5):1322 PMID: 34793738 SCOPUS ID: 2-s2.0-85118631244 11/19/2021       1 Citation
  • Clinical Features, Treatment and Outcome of Childhood Glial Tumors. (Kara B, Ertan K, Karabagli P, Karabagli H, Yavas G, Caglayan AO, Koksal Y) Turk Neurosurg 2022;32(1):135-142 PMID: 34751424 SCOPUS ID: 2-s2.0-85123246592 11/10/2021       2 Citations
  • In Regard to Hathout et al. (Onal C, Oymak E, Yavas G) Int J Radiat Oncol Biol Phys 2021 Nov 01;111(3):837-838 PMID: 34560027 SCOPUS ID: 2-s2.0-85114613780 09/25/2021       1 Citation
  • The role of choroidal optical coherence tomography for follow-up of carotid cavernous fistula with anterior drainage. (Arat YO, İnam O, Yavas GF, Arat A) Eye (Lond) 2022 Oct;36(10):2020-2027 PMID: 34408315 PMCID: PMC9500102 SCOPUS ID: 2-s2.0-85113261518 08/20/2021       1 Citation
  • Impact of lymph node ratio in patients with stage IIIC endometrial carcinoma treated with postoperative radiotherapy. (Onal C, Sari SY, Yavas G, Guler OC, Yigit E, Oymak E, Gultekin M, Yildiz F) Future Oncol 2021 Sep;17(25):3321-3330 PMID: 34355983 SCOPUS ID: 2-s2.0-85113366629 08/07/2021       5 Citations
  • Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy. In regard to Vojtíšek et al. (Onal C, Yavas G, Yavas C) Strahlenther Onkol 2021 Oct;197(10):935-936 PMID: 34341837 SCOPUS ID: 2-s2.0-85111821430 08/04/2021    
  • Outcome and safety analysis of endometrial cancer patients treated with postoperative 3D-conformal radiotherapy or intensity modulated radiotherapy. (Onal C, Yuce Sari S, Yavas G, Oymak E, Birgi SD, Yigit E, Guler OC, Gultekin M, Akyurek S, Yildiz F) Acta Oncol 2021 Sep;60(9):1154-1160 PMID: 33999750 SCOPUS ID: 2-s2.0-85106037557 05/18/2021       11 Citations
  • Comment on Hunt et al, "Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer". (Yavas G, Yavas C, Arslan G, Onal C) Clin Transl Radiat Oncol 2021 May;28:88-89 PMID: 33912694 PMCID: PMC8065181 SCOPUS ID: 2-s2.0-85103991629 04/30/2021    
  • Long-term full-field and multifocal electroretinographic changes after treatment with ranibizumab in patients with diabetic macular edema. (Yigit K, Inan ÜÜ, Inan S, Dogan M, Yavas GF, Cetinkaya E) Int Ophthalmol 2021 Apr;41(4):1487-1501 PMID: 33486648 SCOPUS ID: 2-s2.0-85099794210 01/25/2021       6 Citations
  • Effects of Adipose-Derived Stem Cells and Platelet-Rich Plasma for Prevention of Alopecia and Other Skin Complications of Radiotherapy. (Evin N, Tosun Z, Aktan TM, Duman S, Harmankaya I, Yavas G) Ann Plast Surg 2021 May 01;86(5):588-597 PMID: 33141771 SCOPUS ID: 2-s2.0-85105827674 11/04/2020       9 Citations
  • Delayed Radiation Myelopathy in a Child With Hodgkin Lymphoma and ARTEMIS Mutation. (Kara B, Seher N, Ucaryilmaz H, Yavas G, Paksoy Y, Artac H, Stray-Pedersen A, Koksal Y) J Pediatr Hematol Oncol 2021 Apr 01;43(3):e404-e407 PMID: 32341262 SCOPUS ID: 2-s2.0-85084409629 04/29/2020       3 Citations
  • Comment on De Felice et al, "Intensified Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer in Elderly Patients: Toxicity, Disease Control, and Survival Outcomes". (Yavas G, Yavas C) Clin Colorectal Cancer 2019 Dec;18(4):e368-e369 PMID: 31409534 SCOPUS ID: 2-s2.0-85075378599 08/15/2019       1 Citation
  • A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma. (Onal C, Sari SY, Yildirim BA, Yavas G, Gultekin M, Guler OC, Akyurek S, Yildiz F) J Gynecol Oncol 2019 May;30(3):e28 PMID: 30887753 PMCID: PMC6424855 SCOPUS ID: 2-s2.0-85063287897 03/20/2019       32 Citations
  • Treatment outcomes of endometrial cancer patients with paraaortic lymph node metastasis: a multi-institutional analysis. (Onal C, Yildirim BA, Sari SY, Yavas G, Gultekin M, Guler OC, Yildiz F, Akyurek S) Int J Gynecol Cancer 2019 Jan;29(1):94-101 PMID: 30640689 SCOPUS ID: 2-s2.0-85060040501 01/15/2019       9 Citations
  • Adjuvant carboplatin and paclitaxel after concurrent cisplatin and radiotherapy in patients with locally advanced cervical cancer. (Yavas G, Yavas C, Sen E, Oner I, Celik C, Ata O) Int J Gynecol Cancer 2019 Jan;29(1):42-47 PMID: 30640682 SCOPUS ID: 2-s2.0-85060065200 01/15/2019       31 Citations
  • Beta-Hydroxy-Beta-Methyl-Butyrate, L-glutamine, and L-arginine Supplementation Improves Radiation-Induce Acute Intestinal Toxicity. (Yavas C, Yavas G, Celik E, Buyukyoruk A, Buyukyoruk C, Yuce D, Ata O) J Diet Suppl 2019;16(5):576-591 PMID: 29969326 SCOPUS ID: 2-s2.0-85049593670 07/04/2018       15 Citations
  • Sleep quality of endometrial cancer survivors and the effect of treatments. (Tuyan İlhan T, Uçar MG, Gül A, Saymaz İlhan T, Yavaş G, Çelik Ç) Turk J Obstet Gynecol 2017 Dec;14(4):243-248 PMID: 29379668 PMCID: PMC5780569 SCOPUS ID: 2-s2.0-85042421854 01/31/2018       17 Citations
  • Locally advanced squamous cell cervical cancer in a patient with septate uterus. (Yavas G, Yavas C, Inan G) J Contemp Brachytherapy 2017 Oct;9(5):487-489 PMID: 29204170 PMCID: PMC5705835 SCOPUS ID: 2-s2.0-85033385473 12/06/2017       5 Citations
  • Comment on "Serum human epididymis protein 4 is associated with the treatment response of concurrent chemo-radiotherapy and prognosis in patients with locally advanced non-small cell lung cancer" by Lan WG et al. (Yavas G, Yavas C, Akyurek S) Clin Transl Oncol 2018 Jun;20(6):801-802 PMID: 29063355 SCOPUS ID: 2-s2.0-85031920868 10/25/2017    
  • Pelvic radiotherapy does not deteriorate the quality of life of women with gynecologic cancers in long-term follow-up: A 2 years prospective single-center study. (Yavas G, Yavas C, Dogan NU, Ilhan TT, Dogan S, Karabagli P, Ata O, Yuce E, Celik C) J Cancer Res Ther 2017;13(3):524-532 PMID: 28862221 SCOPUS ID: 2-s2.0-85028744957 09/02/2017       12 Citations
  • Spironolactone ameliorates the cardiovascular toxicity induced by concomitant trastuzumab and thoracic radiotherapy. (Yavas G, Celik E, Yavas C, Elsurer C, Afsar RE) Rep Pract Oncol Radiother 2017;22(4):295-302 PMID: 28507459 PMCID: PMC5422008 SCOPUS ID: 2-s2.0-85018741092 05/17/2017       18 Citations
  • An aggressive parameningeal rhabdomyosarcoma with multiple spinal cord metastases: a case report and review of the literature. (Yavas G, Karabagli P, Paksoy Y, Yavas C, Karabagli H, Koksal Y) Childs Nerv Syst 2017 May;33(5):843-847 PMID: 27957633 SCOPUS ID: 2-s2.0-85004154256 12/14/2016       5 Citations
  • Assessment of concomitant versus sequential trastuzumab on radiation-induced cardiovascular toxicity. (Yavas G, Gultekin M, Yildiz O, Seyrek M, Demirkol S, Toy H, Sargon MF, Ozkayar O, Uner A, Yildiz F, Akyol F) Hum Exp Toxicol 2017 Nov;36(11):1121-1130 PMID: 27932539 SCOPUS ID: 2-s2.0-85031086399 12/10/2016       7 Citations
  • The use of concurrent hormonotherapy and radiotherapy does not deteriorate radiation-induced cardiac toxicity. (Yavas C, Yavas G, Toy H, Ata O) Hum Exp Toxicol 2017 Aug;36(8):795-801 PMID: 27596072 SCOPUS ID: 2-s2.0-85024111203 09/07/2016       2 Citations
  • Amelioration of radiation-induced lung injury by halofuginone: An experimental study in Wistar-Albino rats. (Calik M, Yavas G, Calik SG, Yavas C, Celik ZE, Sargon MF, Esme H) Hum Exp Toxicol 2017 Jun;36(6):638-647 PMID: 27457799 SCOPUS ID: 2-s2.0-85019701206 07/28/2016       7 Citations
  • Neutrophil-to-Lymphocyte Ratio as a Marker in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy. (Polat O, Yavaş GF, İnan S, İnan ÜÜ) Balkan Med J 2015 Oct;32(4):382-7 PMID: 26740898 PMCID: PMC4692338 SCOPUS ID: 2-s2.0-84943563535 01/08/2016       28 Citations
  • Hyoid osteoradionecrosis accompanied by candida infection. (Yavaş G, Kara Gedik G, Çolpan B, Ata Ö, Öztürk K, Sarı O) Kulak Burun Bogaz Ihtis Derg 2015;25(5):310-4 PMID: 26476522 SCOPUS ID: 2-s2.0-84973503035 10/20/2015       3 Citations
  • Effect of the percentage of body fat on surgical, clinical and pathological outcomes in women with endometrial cancer. (Kerimoglu OS, Pekin A, Yilmaz SA, Yavas G, Beyhekim F, Demirtaş AA, Dogan NU, İlhan TT, Celik C) J Obstet Gynaecol Res 2015 Mar;41(3):449-55 PMID: 25330937 SCOPUS ID: 2-s2.0-84924720593 10/22/2014       10 Citations
  • The impact of body mass index on radiotherapy technique in patients with early-stage endometrial cancer: a single-center dosimetric study. (Yavas G, Yavas C, Kerimoglu OS, Celik C) Int J Gynecol Cancer 2014 Nov;24(9):1607-15 PMID: 25275659 SCOPUS ID: 2-s2.0-84925940861 10/03/2014       7 Citations
  • Evaluation of the effect of changes in dose rate on rat lung cells. (Hurmuz P, Kivanc H, Canbolat A, Yavas G, Yuce D, Onder SC, Sargon MF, Yildiz F) Technol Cancer Res Treat 2015 Jun;14(3):343-9 PMID: 25223322 SCOPUS ID: 2-s2.0-84954541584 09/17/2014       3 Citations
  • Fluorodeoxyglucose positron emission tomography/computed tomography imaging of a patient with squamous cell carcinoma of prostate. (Kara Gedik G, Yavas G, Akand M, Celik E, Sari O) Case Rep Med 2014;2014:860570 PMID: 24782898 PMCID: PMC3982275 SCOPUS ID: 2-s2.0-85006306988 05/02/2014       6 Citations
  • Aggressive rhabdoid meningioma with osseous, papillary and chordoma-like appearance. (Karabagli P, Karabagli H, Yavas G) Neuropathology 2014 Oct;34(5):475-83 PMID: 24702318 SCOPUS ID: 2-s2.0-84907897955 04/08/2014       11 Citations
  • Comment on Sridharan V et al., 'effects of radiation on the epidermal growth factor receptor pathway in the heart'. (Yavas G, Yavas C) Int J Radiat Biol 2014 Apr;90(4):334-5 PMID: 24456545 SCOPUS ID: 2-s2.0-84897509654 01/25/2014    
  • Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer. (Akyurek S, Yavas G) Exp Oncol 2013 Dec;35(4):267-71 PMID: 24382436 SCOPUS ID: 2-s2.0-84892702839 01/03/2014       7 Citations
  • Postmastectomy radiation therapy in locally advanced breast cancer. (Yavas G, Yavas C, Akyurek N) Exp Oncol 2013 Dec;35(4):258-66 PMID: 24382435 SCOPUS ID: 2-s2.0-84892748518 01/03/2014       3 Citations
  • Basal renal function reserve and mean kidney dose predict future radiation-induced kidney injury in stomach cancer patients. (Yavas G, Elsurer R, Yavas C, Ata O) Support Care Cancer 2014 Feb;22(2):445-51 PMID: 24197055 SCOPUS ID: 2-s2.0-84896047730 11/08/2013       8 Citations
  • Intracranial metastasis of neuroblastoma: in two different areas at the same time. (Kose D, Karabagli P, Yavas G, Karabagli H, Koksal Y) Childs Nerv Syst 2013 Oct;29(10):1799-802 PMID: 23793924 SCOPUS ID: 2-s2.0-84884354945 06/25/2013       4 Citations
  • Does spironolactone ameliorate trastuzumab-induced cardiac toxicity? (Yavas G, Elsurer R, Yavas C, Elsurer C, Ata O) Med Hypotheses 2013 Aug;81(2):231-4 PMID: 23688742 SCOPUS ID: 2-s2.0-84880036281 05/22/2013       8 Citations
  • Comparison of "sandwich chemo-radiotherapy" and six cycles of chemotherapy followed by adjuvant radiotherapy in patients with stage IIIC endometrial cancer: a single center experience. (Dogan NU, Yavas G, Yavas C, Ata O, Yılmaz SA, Celik C) Arch Gynecol Obstet 2013 Oct;288(4):845-50 PMID: 23553195 SCOPUS ID: 2-s2.0-84885376812 04/05/2013       8 Citations
  • The effect of Halofuginone in the amelioration of radiation induced-lung fibrosis. (Yavas G, Calik M, Calik G, Yavas C, Ata O, Esme H) Med Hypotheses 2013 Apr;80(4):357-9 PMID: 23352286 SCOPUS ID: 2-s2.0-84875389408 01/29/2013       16 Citations
  • Dosimetric comparison of 3-dimensional conformal and field-in-field radiotherapy techniques for the adjuvant treatment of early stage endometrial cancer. (Yavas G, Yavas C, Acar H, Buyukyoruk A, Cobanoglu G, Kerimoglu OS, Yavas O, Celik C) Phys Med 2013 Nov;29(6):577-82 PMID: 23219336 SCOPUS ID: 2-s2.0-84885948290 12/12/2012       13 Citations
  • A case of von Hippel-Lindau disease with juxtapapillary retinal capillary hemangioma and nutcracker phenomenon. (Yavaş GF, Okur N, Küsbeci T, Norman E, Inan Ü) Int Ophthalmol 2013 Jun;33(3):309-14 PMID: 23114531 SCOPUS ID: 2-s2.0-84877920931 11/02/2012       3 Citations
  • Amelioration of radiation-induced acute inflammation and mucosal atrophy by beta-hydroxy-beta-methylbutyrate, L-glutamıne, and L-argınıne: results of an experimental study. (Yavas C, Yavas G, Acar H, Toy H, Yuce D, Akyurek S, Ata O) Support Care Cancer 2013 Mar;21(3):883-8 PMID: 22993027 SCOPUS ID: 2-s2.0-84874118854 09/21/2012       13 Citations
  • Comparison of the effects of aromatase inhibitors and tamoxifen on radiation-induced lung toxicity: results of an experimental study. (Yavas G, Yavas C, Acar H, Toy H, Yuce D, Ata O) Support Care Cancer 2013 Mar;21(3):811-7 PMID: 22941118 SCOPUS ID: 2-s2.0-84874111364 09/04/2012       20 Citations
  • HER-2 positive primary solid neuroendocrine carcinoma of the breast: a case report and review of the literature. (Yavas G, Karabagli P, Araz M, Yavas C, Ata O) Breast Cancer 2015 Jul;22(4):432-6 PMID: 22711316 SCOPUS ID: 2-s2.0-84932625651 06/20/2012       6 Citations
  • Evaluation of the acute effect of palonosetron on transmural dispersion of myocardial repolarization. (Dogan U, Yavas G, Tekinalp M, Yavas C, Ata OY, Ozdemir K) Eur Rev Med Pharmacol Sci 2012 Apr;16(4):462-8 PMID: 22696873 SCOPUS ID: 2-s2.0-84862681283 06/16/2012       22 Citations
  • Prospective assessment of quality of life and psychological distress in patients with gynecologic malignancy: a 1-year prospective study. (Yavas G, Dogan NU, Yavas C, Benzer N, Yuce D, Celik C) Int J Gynecol Cancer 2012 Jul;22(6):1096-101 PMID: 22672986 SCOPUS ID: 2-s2.0-84863634979 06/08/2012       24 Citations
  • Comment on "Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study" by Ferrandina et al. (GYNECOL ONCOL 2012; 124:389-394). (Yavas G, Yavas C) Gynecol Oncol 2012 Jul;126(1):167; author reply 167-8 PMID: 22433463 SCOPUS ID: 2-s2.0-84862757540 03/22/2012       1 Citation
  • Acute effect of palonosetron on electrocardiographic parameters in cancer patients: a prospective study. (Yavas C, Dogan U, Yavas G, Araz M, Ata OY) Support Care Cancer 2012 Oct;20(10):2343-7 PMID: 22170340 SCOPUS ID: 2-s2.0-84868467323 12/16/2011       36 Citations
  • Health-related quality of life in high-grade glioma patients: a prospective single-center study. (Yavas C, Zorlu F, Ozyigit G, Gurkaynak M, Yavas G, Yuce D, Cengiz M, Yildiz F, Akyol F) Support Care Cancer 2012 Oct;20(10):2315-25 PMID: 22160582 SCOPUS ID: 2-s2.0-84868456975 12/14/2011       51 Citations
  • Prospective assessment of health-related quality of life in patients with low-grade glioma: a single-center experience. (Yavas C, Zorlu F, Ozyigit G, Gurkaynak M, Yavas G, Yuce D, Cengiz M, Yildiz F, Akyol F) Support Care Cancer 2012 Aug;20(8):1859-68 PMID: 21979904 SCOPUS ID: 2-s2.0-84863990536 10/08/2011       19 Citations
  • Concomitant trastuzumab with thoracic radiotherapy: a morphological and functional study. (Yavas G, Yildiz F, Guler S, Sargon MF, Yildiz D, Yolcu T, Tuncer M, Akyol FH) Ann Oncol 2011 May;22(5):1120-1126 PMID: 21097554 SCOPUS ID: 2-s2.0-79955500305 11/26/2010       13 Citations
    • Last update: 03/26/2026